Simonetti, Giorgia http://orcid.org/0000-0001-6954-969X
Mengucci, Carlo
Padella, Antonella http://orcid.org/0000-0001-9991-992X
Fonzi, Eugenio http://orcid.org/0000-0001-8389-8220
Picone, Gianfranco
Delpino, Claudio
Nanni, Jacopo
De Tommaso, Rossella
Franchini, Eugenia
Papayannidis, Cristina
Marconi, Giovanni
Pazzaglia, Martina
Perricone, Margherita
Scarpi, Emanuela http://orcid.org/0000-0001-7230-9267
Fontana, Maria Chiara
Bruno, Samantha
Tebaldi, Michela
Ferrari, Anna http://orcid.org/0000-0002-7022-9906
Bochicchio, Maria Teresa
Ghelli Luserna Di Rorà, Andrea
Ghetti, Martina
Napolitano, Roberta
Astolfi, Annalisa
Baldazzi, Carmen
Guadagnuolo, Viviana
Ottaviani, Emanuela
Iacobucci, Ilaria http://orcid.org/0000-0003-2008-1365
Cavo, Michele
Castellani, Gastone
Haferlach, Torsten
Remondini, Daniel http://orcid.org/0000-0003-3185-7456
Capozzi, Francesco http://orcid.org/0000-0002-5543-2359
Martinelli, Giovanni
Funding for this research was provided by:
European Hematology Association (EHA Research Fellowship)
Ministero della Salute (GR-2018-12365278)
Article History
Received: 11 March 2021
Revised: 21 May 2021
Accepted: 2 June 2021
First Online: 30 June 2021
Competing interests
: The authors declare the following competing interests: II received honoraria from Amgen; TH is part owner of MLL Munich Leukemia Laboratory; GM reports compensation from Amgen, Incyte, Janssen, Jazz Pharmaceuticals, AbbVie and Daiichi Sankyo (consultancy), Pfizer and Celgene (consultancy and speakers’ bureau), Novartis (speakers’ bureau), outside the submitted work. The other authors have declared that no conflict of interest exists.
: The study was approved by the Institutional Ethics Committees (protocol 253/2013/O/Tess, 112/2014/U/Tess, Policlinico Sant’Orsola-Malpighi; internal MLL board and SOP-EN-ISO-15189) and was carried out in accordance with the principles laid down in the 1964 Declaration of Helsinki. Written informed consent was received from participants prior to inclusion in the study.